NuvoBio
PrivateLast Round
Accelerator
Mar 13, 2026
Total Funding Raised
$173,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
NuvoBio operates in Healthcare & Life Sciences and is based in Ottawa. Its latest recorded funding round was an Accelerator round in March 2026.
NuvoBio is a biotechnology company that develops a bio-medical technology platform designed to expedite the development of peptide therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NuvoBio Comparables
Compare NuvoBio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Menten AI | 89% | |
| ProteinQure | 86% | |
| Fable Therapeutics | 84% |
For institutional investors. Book with your work email.
NuvoBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Mar 13, 2026 | ||||
| Grant | Dec 3, 2024 | ||||
| Accelerator | May 1, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
NuvoBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Federal Economic Development Agency for Southern Ontario | Grant |
| Consortium Québécois sur la découverte du médicament | Accelerator |
| Creative Destruction Lab | Accelerator |
| Capital BioVentures | Grant |
| Merck Digital Sciences Studio | Accelerator |
| The Venture Collective | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 406% MoM to 1.3K.
- Mar 13, 2026
$100K raised, led by Merck Digital Sciences Studio.
For institutional investors. Book with your work email.
NuvoBio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about NuvoBio's valuation, stock price, and market status.
Is NuvoBio a public or private company?
NuvoBio is a private company.
What is the current stock price of NuvoBio?
NuvoBio is a private company, so its shares have no public market price. Caplight tracks NuvoBio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is NuvoBio worth (valuation)?
Valuation information for NuvoBio is not publicly available.
Can I buy NuvoBio stock?
NuvoBio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was NuvoBio's last funding round?
NuvoBio's most recent funding round was Accelerator on March 13, 2026.
Who are the main investors in NuvoBio?
Key investors in NuvoBio include Capital BioVentures, Merck Digital Sciences Studio.
Will NuvoBio IPO soon?
No public IPO plans have been announced for NuvoBio.
How can I track NuvoBio secondary market activity?
Caplight tracks bids, offers, and trades in NuvoBio's shares on secondary markets.